vs

Side-by-side financial comparison of Arcellx, Inc. (ACLX) and JEWETT CAMERON TRADING CO LTD (JCTC). Click either name above to swap in a different company.

JEWETT CAMERON TRADING CO LTD is the larger business by last-quarter revenue ($8.7M vs $8.1M, roughly 1.1× Arcellx, Inc.). JEWETT CAMERON TRADING CO LTD runs the higher net margin — -45.6% vs -766.0%, a 720.4% gap on every dollar of revenue. On growth, JEWETT CAMERON TRADING CO LTD posted the faster year-over-year revenue change (-6.6% vs -79.3%). Over the past eight quarters, JEWETT CAMERON TRADING CO LTD's revenue compounded faster (2.5% CAGR vs -24.6%).

Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.

Jewett Cameron Trading Co Ltd (ticker JCTC) is a US-based distribution firm offering construction hardware, industrial supplies, outdoor living, and home improvement goods. It serves retail, commercial construction, and wholesale clients across North America, with core segments in building materials and outdoor recreation.

ACLX vs JCTC — Head-to-Head

Bigger by revenue
JCTC
JCTC
1.1× larger
JCTC
$8.7M
$8.1M
ACLX
Growing faster (revenue YoY)
JCTC
JCTC
+72.7% gap
JCTC
-6.6%
-79.3%
ACLX
Higher net margin
JCTC
JCTC
720.4% more per $
JCTC
-45.6%
-766.0%
ACLX
Faster 2-yr revenue CAGR
JCTC
JCTC
Annualised
JCTC
2.5%
-24.6%
ACLX

Income Statement — Q1 FY2025 vs Q1 FY2026

Metric
ACLX
ACLX
JCTC
JCTC
Revenue
$8.1M
$8.7M
Net Profit
$-62.3M
$-3.9M
Gross Margin
-12.5%
Operating Margin
-847.6%
-43.7%
Net Margin
-766.0%
-45.6%
Revenue YoY
-79.3%
-6.6%
Net Profit YoY
-765.1%
-498.8%
EPS (diluted)
$-1.13
$-1.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACLX
ACLX
JCTC
JCTC
Q4 25
$8.7M
Q3 25
$10.4M
Q2 25
$12.6M
Q1 25
$8.1M
$9.1M
Q4 24
$15.3M
$9.3M
Q3 24
$26.0M
$13.2M
Q2 24
$27.4M
$15.9M
Q1 24
$39.3M
$8.2M
Net Profit
ACLX
ACLX
JCTC
JCTC
Q4 25
$-3.9M
Q3 25
$-2.2M
Q2 25
$-649.6K
Q1 25
$-62.3M
$-573.1K
Q4 24
$-47.1M
$-658.7K
Q3 24
$-25.9M
$-190.5K
Q2 24
$-27.2M
$154.9K
Q1 24
$-7.2M
$-534.1K
Gross Margin
ACLX
ACLX
JCTC
JCTC
Q4 25
-12.5%
Q3 25
8.2%
Q2 25
15.0%
Q1 25
20.1%
Q4 24
18.3%
Q3 24
14.5%
Q2 24
18.6%
Q1 24
25.1%
Operating Margin
ACLX
ACLX
JCTC
JCTC
Q4 25
-43.7%
Q3 25
-13.8%
Q2 25
-5.5%
Q1 25
-847.6%
-8.5%
Q4 24
-348.2%
-9.3%
Q3 24
-129.1%
-2.3%
Q2 24
-127.8%
0.3%
Q1 24
-40.3%
-8.8%
Net Margin
ACLX
ACLX
JCTC
JCTC
Q4 25
-45.6%
Q3 25
-21.7%
Q2 25
-5.2%
Q1 25
-766.0%
-6.3%
Q4 24
-308.4%
-7.1%
Q3 24
-99.4%
-1.4%
Q2 24
-99.3%
1.0%
Q1 24
-18.3%
-6.5%
EPS (diluted)
ACLX
ACLX
JCTC
JCTC
Q4 25
$-1.12
Q3 25
$-0.65
Q2 25
$-0.18
Q1 25
$-1.13
$-0.16
Q4 24
$-0.87
$-0.19
Q3 24
$-0.48
$-0.05
Q2 24
$-0.51
$0.04
Q1 24
$-0.14
$-0.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACLX
ACLX
JCTC
JCTC
Cash + ST InvestmentsLiquidity on hand
$543.3M
$1.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$416.9M
$16.8M
Total Assets
$648.1M
$23.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACLX
ACLX
JCTC
JCTC
Q4 25
$1.0M
Q3 25
$226.2K
Q2 25
$1.2M
Q1 25
$543.3M
$435.6K
Q4 24
$587.4M
$3.0M
Q3 24
$574.3M
$4.9M
Q2 24
$516.7M
$1.1M
Q1 24
$573.9M
$1.1M
Stockholders' Equity
ACLX
ACLX
JCTC
JCTC
Q4 25
$16.8M
Q3 25
$20.8M
Q2 25
$23.0M
Q1 25
$416.9M
$23.7M
Q4 24
$454.8M
$24.2M
Q3 24
$483.0M
$24.9M
Q2 24
$487.2M
$25.0M
Q1 24
$496.6M
$24.9M
Total Assets
ACLX
ACLX
JCTC
JCTC
Q4 25
$23.2M
Q3 25
$25.5M
Q2 25
$29.2M
Q1 25
$648.1M
$27.6M
Q4 24
$711.3M
$26.7M
Q3 24
$764.9M
$27.5M
Q2 24
$734.3M
$28.3M
Q1 24
$779.7M
$29.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACLX
ACLX
JCTC
JCTC
Operating Cash FlowLast quarter
$-63.1M
$-1.3M
Free Cash FlowOCF − Capex
$-63.9M
FCF MarginFCF / Revenue
-786.4%
Capex IntensityCapex / Revenue
9.6%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-122.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACLX
ACLX
JCTC
JCTC
Q4 25
$-1.3M
Q3 25
$-636.4K
Q2 25
$-1.6M
Q1 25
$-63.1M
$-2.6M
Q4 24
$-46.0M
$-1.8M
Q3 24
$30.7M
$3.8M
Q2 24
$-36.2M
$14.5K
Q1 24
$-31.9M
$-2.4M
Free Cash Flow
ACLX
ACLX
JCTC
JCTC
Q4 25
Q3 25
$-658.0K
Q2 25
$-1.7M
Q1 25
$-63.9M
$-2.6M
Q4 24
$-47.5M
$-1.8M
Q3 24
$28.4M
Q2 24
$-39.5M
$-96.1K
Q1 24
$-38.3M
FCF Margin
ACLX
ACLX
JCTC
JCTC
Q4 25
Q3 25
-6.3%
Q2 25
-13.1%
Q1 25
-786.4%
-28.8%
Q4 24
-311.3%
-19.6%
Q3 24
109.2%
Q2 24
-144.1%
-0.6%
Q1 24
-97.7%
Capex Intensity
ACLX
ACLX
JCTC
JCTC
Q4 25
0.0%
Q3 25
0.2%
Q2 25
0.3%
Q1 25
9.6%
0.2%
Q4 24
9.8%
0.4%
Q3 24
8.8%
0.0%
Q2 24
11.7%
0.7%
Q1 24
16.4%
0.0%
Cash Conversion
ACLX
ACLX
JCTC
JCTC
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.09×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACLX
ACLX

Segment breakdown not available.

JCTC
JCTC

Lawn Garden Pet And Other$7.4M86%
Industrial Wood Products$1.2M14%

Related Comparisons